Sphingolipid metabolism is spatially regulated in the developing embryo bySOXEgenes

Abstract

AbstractDuring epithelial-to-mesenchymal transition (EMT), significant rearrangements occur in plasma membrane protein and lipid content that are important for membrane function and acquisition of cell motility. To gain insight into how neural crest cells regulate their lipid content at the transcriptional level during EMT, here we identify critical enhancer sequences that regulate the expression ofSMPD3, a gene responsible for sphingomyelin hydrolysis to produce ceramide, which is necessary for neural crest EMT. We uncovered three enhancer regions within the first intron of theSMPD3locus that drive reporter expression in distinct spatial and temporal domains, together collectively recapitulating the expression domains of endogenousSMPD3within the ectodermal lineages. We further dissected one enhancer that is specifically active in the migrating neural crest. By mutating putative transcriptional input sites or knocking down upstream regulators, we find that the SoxE-family transcription factors Sox9 and Sox10 regulate the expression ofSMPD3in migrating neural crest cells. Together these results shed light on how core components of developmental gene regulatory networks interact with metabolic effector genes to control changes in membrane lipid content.HighlightsSMPD3is expressed in the neural tube, neural crest, and notochord during early developmentSMPD3expression is regulated by at least three intronic enhancersSox10 and its binding sites are required for expression by a migratory neural crest-specificSMPD3enhancerSox10 is a positive regulator of endogenousSMPD3expression during neural crest migration